Giovanni Fattore - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Giovanni Fattore's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Giovanni Fattore
Verified
Associate Editor, Health Policy
Beats
policy, elections drugs, legislationmarijuana, cannabis psychedelics, politics
Country music, Americana music
Content
COVID-19-related hospitalizations in Italy: an application of the synthetic control method to investigate the trajectory of diagnosis-related group 79 and its counterfactual during 2010-2021: Expert Review of Pharmacoeconomics & Outcomes Research: Vol 0,
By Carlo Lazzaro, Giovanni Fattore Verified, Angelo Guido Corsico| Taylor & Francis@ ABSTRACTBackground With 10.95 million cases (11 March 2020-9 February 2022), Italy was massively hit by the coronavirus disease 2019 (COVID-19) pandemic. Most of the COVID-19-related inpatient discharges were codified under the Diagnosis-Related Group (DRG) 79. During 2019–2021, DRG 79 inpatient discharges increased from 20,377 to 130,580 (+540.82%).
By Marco Silano, Carlo Agostoni, Giovanni Fattore Verified| Archives of Disease in Childhood Verified Italy’s unsolved childhood obesity crisis Marco Silano1, Carlo Agostoni2,3, Giovanni Fattore4 1 Unit of Human Nutrition and Health, Department of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, Rome, Italy 2 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, UO Pediatria Media Intensità di Cura, Milan, Italy 3 Department of Clinical Sciences and Community Health (DISCCO), University of Milano, Milan, Italy 4 Department of Policy Analysis and Public...
COVID-19-related hospitalizations in Italy: an application of the synthetic control method to investigate the trajectory of diagnosis-related group 79 and its counterfactual during 2010-2021: Expert Review of Pharmacoeconomics & Outcomes Research: Vol 0,
By Carlo Lazzaro, Giovanni Fattore Verified, Angelo Guido Corsico| Taylor & Francis@ ABSTRACTBackground With 10.95 million cases (11 March 2020-9 February 2022), Italy was massively hit by the coronavirus disease 2019 (COVID-19) pandemic. Most of the COVID-19-related inpatient discharges were codified under the Diagnosis-Related Group (DRG) 79. During 2019–2021, DRG 79 inpatient discharges increased from 20,377 to 130,580 (+540.82%).
Company Info
Health Policy
The Health Policy Institute of Ohio (HPIO) is a nonprofit organization founded in 2003 to tackle health policy challenges in Ohio. As the state's only independent entity focused solely on health policy analysis, HPIO aims to advance evidence-informed policies that improve health outcomes, promote equity, and ensure sustainable healthcare spending. HPIO's mission is to provide nonpartisan analysis that informs state health policy decisions, enhancing health value through improved population health and cost sustainability. The organization engages in policy development, stakeholder convening, and research, producing reports and tools to guide policymakers. HPIO also advocates for evidence-based strategies to reduce health disparities without engaging in lobbying. HPIO serves public policymakers, healthcare providers, public health professionals, and philanthropic organizations committed to health equity. Its work includes creating policy briefs, health value dashboards, and online resources for tracking health metrics and spending trends.
Italy, Italy
+1 614-224-4950
Founded: 2003